白细胞介素-1β激活的微血管内皮细胞促进DC-SIGN阳性替代活化巨噬细胞生成并参与系统性硬化症皮肤纤维化机制
该研究探讨白细胞介素-1β与微血管内皮细胞在系统性硬化症皮肤替代活化巨噬细胞生成及皮肤纤维化中的作用。利用患者与健康供者皮肤来源微血管内皮细胞条件培养基诱导巨噬细胞极化,发现DC-SIGN阳性替代活化巨噬细胞高分泌CCL18、CCL2、CXCL8而低分泌IL-10,可增强促炎成纤维细胞生成,并在高纤维化严重度评分患者皮肤血管周围富集;基于体外结果构建的皮肤转录组巨噬细胞特征评分与皮肤纤维化范围相关(Spearman r=0.6,P=0.0018),并与早期疾病表现及肺部受累相关。
要点
- 系统性硬化症患者IL-1β激活的微血管内皮细胞诱导单核细胞分化为DC-SIGN阳性替代活化巨噬细胞。
- 该类巨噬细胞高分泌CCL18、CCL2、CXCL8而低分泌IL-10,并增强促炎成纤维细胞生成。
- 皮肤巨噬细胞特征评分与皮肤纤维化范围相关(r=0.6,P=0.0018),并与早期表现及肺部受累相关。
核心结论
- 研究结果提示IL-1β持续分泌、微血管内皮细胞激活与DC-SIGN阳性替代活化巨噬细胞生成之间的恶性循环参与系统性硬化症患者皮肤纤维化的发展。
研究设计与样本
- 研究采用健康供者与系统性硬化症患者皮肤纯化的微血管内皮细胞制备条件培养基,用于生成单核细胞来源巨噬细胞。
- 使用流式细胞术、多重蛋白检测、实时定量聚合酶链反应和组织免疫荧光表征微血管内皮细胞诱导的替代活化巨噬细胞极化,并进行共培养实验评估其对成纤维细胞活化的作用。
- 采用多参数免疫荧光和多重免疫染色基因表达在健康供者与系统性硬化症患者皮肤中表征替代活化巨噬细胞,并基于体外数据定义监督性巨噬细胞基因特征评分,用Spearman检验评估其与临床特征的相关性。
主要发现
- 系统性硬化症患者IL-1β激活的微血管内皮细胞诱导单核细胞分化为DC-SIGN阳性替代活化巨噬细胞,该类细胞产生高水平CCL18、CCL2和CXCL8而低水平IL-10。
- DC-SIGN阳性替代活化巨噬细胞对促进促炎成纤维细胞生成显示显著增强作用,并在高纤维化严重度评分系统性硬化症患者皮肤血管周围区域富集。
- 基于体外发现定义的皮肤转录组巨噬细胞特征与皮肤纤维化范围相关(Spearman r=0.6,P=0.0018),并与系统性硬化症患者早期疾病表现及肺部受累相关。
关键数值与推荐
- 皮肤转录组巨噬细胞特征评分与皮肤纤维化范围相关(Spearman r=0.6,P=0.0018)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize the role of interleukin-1β (IL-1β) and microvascular endothelial cells (MVECs) in the generation of alternatively activated macrophages in the skin, and to explore their role in the development of skin fibrosis in patients with systemic sclerosis (SSc; scleroderma). METHODS: Conditioned medium prepared with MVECs purified from the skin of healthy donors and the skin of SSc patients was used to generate monocyte-derived macrophages. Flow cytometry, multiplex protein assessment, real-time quantitative polymerase chain reaction, and tissue immunofluorescence were used to characterize MVEC-induced polarization of alternatively activated macrophages. Coculture experiments were conducted to assess the role of MVEC-induced alternatively activated macrophages in fibroblast activation. Alternatively activated macrophages were characterized in the skin of healthy donors and SSc patients using multiparametric immunofluorescence and multiplex immunostaining for gene expression. Based on our in vitro data, we defined a supervised macrophage gene signature score to assess correlation between the macrophage score and clinical features in patients with SSc, using the Spearman's test. RESULTS: IL-1β-activated MVECs from SSc patients induced monocytes to differentiate into DC-SIGN+ alternatively activated macrophages producing high levels of CCL18, CCL2, and CXCL8 but low levels of IL-10. DC-SIGN+ alternatively activated macrophages showed significant enhancing effects in promoting the production of proinflammatory fibroblasts and were found to be enriched in perivascular regions of the skin of SSc patients who had a high fibrosis severity score. A novel skin transcriptomic macrophage signature, defined from our in vitro findings, correlated with the extent of skin fibrosis (Spearman's r = 0.6, P = 0.0018) and was associated with early disease manifestations and lung involvement in patients with SSc. CONCLUSION: Our findings shed new light on the vicious circle implicating unabated IL-1β secretion, MVEC activation, and the generation of DC-SIGN+ alternatively activated macrophages in the development of skin fibrosis in patients with SSc.
引用
- Laurent P, Lapoirie J, Leleu D, et al. Interleukin-1β-Activated Microvascular Endothelial Cells Promote DC-SIGN-Positive Alternatively Activated Macrophages as a Mechanism of Skin Fibrosis in Systemic Sclerosis. Arthritis Rheumatol. 2022. PMID: 34962361. doi:10.1002/art.42061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。